|Mr. Evan M. Levine||Co-Founder, CEO & Chairman||N/A||N/A||1966|
|Mr. Noah Isidore Davis||CFO, Sec. & Director||N/A||N/A||1983|
|Mr. Ross Carmel||Chief Legal Officer & Director||N/A||N/A||N/A|
|Dr. Michael Spigarelli M.B.A., M.B.E., M.D., Ph.D.||Chief Medical Officer||N/A||N/A||N/A|
|Mr. Andrew Jones||Inventor & Chairman of Scientific Advisory Board||N/A||N/A||N/A|
PsyBio Therapeutics Corp., a biotechnology company, develops formulations of psychoactive medications produced by genetically modified bacteria for the treatment of mental health and other disorders in the United States. It also engages in the research and development of naturally occurring tryptamines in varieties of magic mushrooms, dimethyltryptamine which have therapeutics properties. The company was incorporated in 2020 and is headquartered in Coconut Creek, Florida.
PsyBio Therapeutics Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.